PetMed Express, Inc. (PETS) Financials
PETS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 159.3 million | 45.6 million |
| 2023-06-30 | 180.7 million | 62.4 million |
| 2023-03-31 | 164.1 million | 40.3 million |
| 2022-12-31 | 165.1 million | 31.5 million |
PETS Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -1.8 million | 1.7 million |
| 2023-06-30 | -591000 | 1.8 million |
| 2023-03-31 | 7.8 million | 1.6 million |
| 2022-12-31 | 12.0 million | 1.8 million |
PETS Net Income
| Date | Net Income |
|---|---|
| 2023-09-30 | -70000 |
| 2023-06-30 | -887000 |
| 2023-03-31 | -5.1 million |
| 2022-12-31 | -19000 |
PETS Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 53.5 million | - | 1.8 million |
| 2023-06-30 | 61.5 million | - | 2.1 million |
| 2023-03-31 | 104.1 million | - | - |
| 2022-12-31 | 102.4 million | - | - |
PETS Shares Outstanding
PETS Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 984000 | - | 13.3 million | 5.5 million |
| 2023-06-30 | 1.2 million | - | 15.7 million | 7.3 million |
| 2023-03-31 | 1.9 million | - | 18.9 million | 4.6 million |
| 2022-12-31 | 993000 | - | 10.4 million | 4.6 million |
PETS Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | 71.0 million | 50.9 million |
| 2023-06-30 | 78.2 million | 55.7 million |
| 2023-03-31 | 62.4 million | 45.0 million |
| 2022-12-31 | 58.9 million | 43.6 million |
PETS
Price: $4.11
Dividend Yield: 0.26%
Forward Dividend Yield: 14.60%
Payout Ratio: -200.00%
Dividend Per Share: 0.60 USD
Earnings Per Share: -0.30 USD
P/E Ratio: -19.57
Exchange: NMS
Sector: Healthcare
Industry: Pharmaceutical Retailers
Volume: 271900
Ebitda: 12.0 millionMarket Capitalization: 94.1 million
Average Dividend Frequency: 4
Years Paying Dividends: 15
DGR3: 2.97%
DGR5: 4.42%
DGR10: 7.02%